Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis.

Mycobacterium tuberculosis adjuvant antigen epitope peptide-based vaccine protein-based vaccine subunit vaccine tuberculosis

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
15 12 2020
Historique:
received: 19 11 2020
revised: 11 12 2020
accepted: 14 12 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 22 6 2021
Statut: epublish

Résumé

The World Health Organization (WHO) herald of the "End TB Strategy" has defined goals and targets for tuberculosis prevention, care, and control to end the global tuberculosis endemic. The emergence of drug resistance and the relative dreadful consequences in treatment outcome has led to increased awareness on immunization against

Identifiants

pubmed: 33333744
pii: cells9122673
doi: 10.3390/cells9122673
pmc: PMC7765234
pii:
doi:

Substances chimiques

Peptides 0
Proteins 0
Tuberculosis Vaccines 0
Vaccines, Subunit 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Vaccines (Basel). 2019 Jul 01;7(3):
pubmed: 31266253
Tuberculosis (Edinb). 2013 Mar;93(2):143-9
pubmed: 23410889
Front Immunol. 2020 Feb 27;11:316
pubmed: 32174919
Front Microbiol. 2020 Jan 30;10:3154
pubmed: 32082273
Int J Biol Macromol. 2018 Oct 15;118(Pt A):180-188
pubmed: 29920369
Lancet. 2013 Mar 23;381(9871):1021-8
pubmed: 23391465
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15520-5
pubmed: 25288770
Hum Vaccin Immunother. 2016 Nov;12(11):2813-2832
pubmed: 27448625
Mol Immunol. 2018 May;97:56-62
pubmed: 29567319
Front Immunol. 2019 Nov 29;10:2807
pubmed: 31849981
Cell. 2020 May 28;181(5):969-977
pubmed: 32437659
Tuberculosis (Edinb). 2019 May;116S:S34-S41
pubmed: 31064713
Clin Cancer Res. 2018 Jul 1;24(13):3014-3025
pubmed: 29545464
JAMA. 2004 May 5;291(17):2086-91
pubmed: 15126436
Front Immunol. 2017 Oct 05;8:1262
pubmed: 29051764
Lancet Respir Med. 2014 Apr;2(4):321-38
pubmed: 24717628
Cancer Res. 2000 Jul 15;60(14):3782-9
pubmed: 10919651
Lancet. 2020 May 16;395(10236):1545-1546
pubmed: 32359402
Vaccine. 2012 Dec 14;30(52):7513-21
pubmed: 23103299
Eur J Immunol. 2000 Jun;30(6):1724-32
pubmed: 10898510
Chem Sci. 2016 Feb 1;7(2):842-854
pubmed: 28791117
Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1405-1425
pubmed: 32060754
Tuberculosis (Edinb). 2011 Jan;91(1):8-13
pubmed: 20980200
J Immunol. 2009 Aug 15;183(4):2659-68
pubmed: 19620314
Front Pediatr. 2019 Aug 27;7:350
pubmed: 31508399
BMJ. 2018 Jan 10;360:k66
pubmed: 29321154
J Transl Med. 2018 Oct 11;16(1):279
pubmed: 30305097
NPJ Vaccines. 2018 Sep 4;3:34
pubmed: 30210819
Front Microbiol. 2020 Mar 11;11:332
pubmed: 32218774
Vaccines (Basel). 2019 Aug 27;7(3):
pubmed: 31461944
Clin Cancer Res. 2019 Jul 15;25(14):4248-4254
pubmed: 31036542
J Med Chem. 2019 Sep 12;62(17):8080-8089
pubmed: 31373811
Infect Immun. 2018 Jun 21;86(7):
pubmed: 29661928
NPJ Vaccines. 2017;2:
pubmed: 28775896
Lancet Infect Dis. 2020 Mar;20(3):e28-e37
pubmed: 32014117
Infect Immun. 2011 Oct;79(10):4042-9
pubmed: 21807910
JAMA. 2020 Jun 9;323(22):2340-2341
pubmed: 32401274
Lancet Respir Med. 2018 Apr;6(4):287-298
pubmed: 29595510
BMC Res Notes. 2017 Aug 30;10(1):434
pubmed: 28854957
Future Microbiol. 2015;10(7):1177-94
pubmed: 26119086
Mucosal Immunol. 2014 May;7(3):670-83
pubmed: 24172845
Int J Infect Dis. 2017 Mar;56:263-267
pubmed: 27816661
Microorganisms. 2019 Aug 12;7(8):
pubmed: 31409028
Biochim Biophys Acta. 2005 Dec 10;1718(1-2):22-31
pubmed: 16321607
Trends Immunol. 2018 May;39(5):419-433
pubmed: 29429859
Sci Rep. 2018 Aug 21;8(1):12519
pubmed: 30131591
Trends Pharmacol Sci. 2018 Jun;39(6):573-585
pubmed: 29655658
Clin Vaccine Immunol. 2015 Sep;22(9):1060-9
pubmed: 26202436
Immunology. 2014 Apr;141(4):506-13
pubmed: 24754048
Cell Mol Immunol. 2018 Feb;15(2):182-184
pubmed: 28890542
Clin Microbiol Rev. 2020 Jun 24;33(4):
pubmed: 32580969
Nanoscale. 2020 Jan 28;12(4):2515-2523
pubmed: 31930264
Clin Infect Dis. 2014 Feb;58(4):470-80
pubmed: 24336911
Vaccines (Basel). 2020 Jul 10;8(3):
pubmed: 32664421
N Engl J Med. 2019 Dec 19;381(25):2429-2439
pubmed: 31661198
Nat Med. 2020 Jun;26(6):811-812
pubmed: 32398877
Semin Immunopathol. 2020 Jun;42(3):315-331
pubmed: 32189035
Vaccine. 2015 Jul 9;33(30):3592-9
pubmed: 26048780
Am J Respir Crit Care Med. 2019 Jan 15;199(2):220-231
pubmed: 30092143
Front Immunol. 2019 Nov 29;10:2806
pubmed: 31849980
Lancet Infect Dis. 2018 Aug;18(8):828-829
pubmed: 30064668
Vaccines (Basel). 2019 Nov 01;7(4):
pubmed: 31683812
F1000Res. 2018 Nov 1;7:1732
pubmed: 30613395
J Transl Med. 2017 Oct 6;15(1):201
pubmed: 28985739
Semin Immunol. 2018 Oct;39:4-13
pubmed: 30396811
Tuber Lung Dis. 2000;80(4-5):173-84
pubmed: 11052906
NPJ Vaccines. 2019 Jan 3;4:1
pubmed: 30622742
Int J Epidemiol. 2018 Feb 1;47(1):193-201
pubmed: 29025083
Front Immunol. 2018 Nov 29;9:2778
pubmed: 30555469
Future Oncol. 2020 Jul;16(19):1323-1325
pubmed: 32406253
Clin Microbiol Rev. 2011 Apr;24(2):351-76
pubmed: 21482729
Sci Rep. 2017 Aug 17;7(1):8582
pubmed: 28819247
Nat Rev Immunol. 2020 Jun;20(6):335-337
pubmed: 32393823
J Infect Dis. 2011 Nov;204(9):1328-38
pubmed: 21933875
Tuberculosis (Edinb). 2019 May;116S:S114-S117
pubmed: 31076321
Vaccine. 2019 May 21;37(23):3022-3030
pubmed: 31040086
Nat Rev Immunol. 2012 Jul 13;12(8):581-91
pubmed: 22790178
Eur Respir J. 2014 Feb;43(2):554-65
pubmed: 23949960
PLoS One. 2011 Jan 26;6(1):e16333
pubmed: 21298114
Cell. 2020 Mar 5;180(5):829-831
pubmed: 32142676
Vaccine. 2014 Dec 12;32(52):7098-107
pubmed: 25454872
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28087945
Nat Rev Drug Discov. 2007 May;6(5):404-14
pubmed: 17473845
N Engl J Med. 2018 Oct 25;379(17):1621-1634
pubmed: 30280651
F1000Res. 2018 Feb 16;7:199
pubmed: 29568497
NPJ Vaccines. 2020 Jan 3;5:2
pubmed: 31908851
Chem Rev. 2020 Mar 25;120(6):3210-3229
pubmed: 31804810
Front Immunol. 2020 May 08;11:970
pubmed: 32574258
Adv Drug Deliv Rev. 2016 Jul 1;102:73-82
pubmed: 26596558
J Immunol. 2007 Mar 15;178(6):3806-13
pubmed: 17339479
Vaccines (Basel). 2020 Jul 11;8(3):
pubmed: 32664505
Mucosal Immunol. 2019 May;12(3):816-826
pubmed: 30760832
Eur J Immunol. 2018 Apr;48(4):705-715
pubmed: 29349774
Infect Immun. 2017 May 23;85(6):
pubmed: 28348055
Am J Respir Crit Care Med. 2011 Mar 15;183(6):696-707
pubmed: 21075901
Sci Rep. 2016 Apr 07;6:23917
pubmed: 27052185

Auteurs

Chiara Bellini (C)

Hevesy György PhD School of Chemistry, Eötvös Loránd University, 1117 Budapest, Hungary.
MTA-ELTE Research Group of Peptide Chemistry, Eötvös Loránd University, 1117 Budapest, Hungary.

Kata Horváti (K)

MTA-ELTE Research Group of Peptide Chemistry, Eötvös Loránd University, 1117 Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH